http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020000925-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a8e95d5b6b71220515f3878c5f799c0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
filingDate 2019-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f413879ebd3e8245e5029d7db9646e93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f4d5415c52cf806bb48e5ba8d6f927f
publicationDate 2020-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2020000925-A1
titleOfInvention Stabilized Aqueous Compositions of Neuromuscular Blocking Agents
abstract The present invention relates to an aqueous composition comprising:n (i) a steroidal neuromuscular blocking agent that is a Rocuronium salt, further wherein the steroidal neuromuscular blocking agent is present at a concentration ranging from 5 mg/mL to 20 mg/mL based on the total volume of the aqueous composition; and (ii) an excipient that includes D-gluconic acid, D-glucono-delta-lactone, or a combination thereof, where the steroidal neuromuscular blocking agent and the excipient are dissolved in a solution consisting of water. nn Furthermore the present invention relates to a liquid pharmaceutical composition comprising or consisting of said aqueous composition and a method for producing said aqueous composition.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2023014293-A1
priorityDate 2012-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA1KZ92
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456728044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159417516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157743692
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450642892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159826209
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458106130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452616209
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448965720
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441290
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451214445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466453612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590331
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160810776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458320623
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160893272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452734735
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158194247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448364546

Total number of triples: 49.